Published in Pharmacol Biochem Behav on July 12, 2009
Therapies for Parkinson's diseases: alternatives to current pharmacological interventions. J Neural Transm (Vienna) (2016) 0.75
Antigenic variation of Borrelia hermsii. J Exp Med (1982) 6.34
Early treatment with nasal continuous positive airway pressure in very low-birth-weight infants. Acta Paediatr (1993) 3.13
Asymptotic distributions of apparent open times and shut times in a single channel record allowing for the omission of brief events. Philos Trans R Soc Lond B Biol Sci (1992) 2.32
Acute hepatitis C infection in HIV positive men who have sex with men in Paris, France, 2001-2004. Euro Surveill (2005) 2.20
Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood (2001) 2.05
Setting the stage for health impact assessment. J Public Health Policy (1997) 1.99
Influence of cold ischemia time, pretransplant anti-porcine antibodies, and donor/recipient size matching on hyperacute graft rejection after discordant porcine to cynomolgus kidney transplantation. Transplantation (2000) 1.69
Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type. Ann Oncol (2009) 1.58
Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells. Leukemia (2004) 1.46
Transplanting the highly sensitized patient: The emory algorithm. Am J Transplant (2006) 1.38
Tail biting in pigs. N Z Vet J (1983) 1.37
Treatment results of advanced neuroblastoma with the first Japanese study group protocol. Study Group of Japan for Treatment of Advanced Neuroblastoma. J Pediatr Hematol Oncol (1999) 1.35
Diagnostic quality and complications of hysterosalpingography: oil- versus water-soluble contrast media--a randomized prospective study. Radiology (1991) 1.28
Permeation of manganese, cadmium, zinc, and beryllium through calcium channels of an insect muscle membrane. Science (1977) 1.22
Costs and benefits of medical student training to a health maintenance organization. JAMA (1986) 1.20
Natural occurrence of the mycotoxin fusarochromanone, a metabolite of Fusarium equiseti, in cereal feed associated with tibial dyschondroplasia. Appl Environ Microbiol (1989) 1.20
European recommendations for the management of healthcare workers occupationally exposed to hepatitis B virus and hepatitis C virus. Euro Surveill (2005) 1.20
Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic stem cell transplantation for BCR-ABL-positive acute lymphoblastic leukemia. Leukemia (2010) 1.19
Therapeutic effect of hysterosalpingography: oil- versus water-soluble contrast media--a randomized prospective study. Radiology (1991) 1.17
Pregnancies before and after HIV diagnosis in a european cohort of HIV-infected women. European Study on the Natural History of HIV Infection in Women. AIDS (2000) 1.12
PBSC collection from family donors in Japan: a prospective survey. Bone Marrow Transplant (2013) 1.09
Experience with International Neuroblastoma Staging System and Pathology Classification. Br J Cancer (2002) 1.06
Graft-versus-tumor effect in a patient with advanced neuroblastoma who received HLA haplo-identical bone marrow transplantation. Bone Marrow Transplant (2003) 1.06
Hematopoietic stem cell transplantation for natural killer-cell lineage neoplasms. Bone Marrow Transplant (2006) 1.05
Surveillance of screening for hepatitis C through the laboratory network RENA-VHC, France, 2000-2001. Euro Surveill (2003) 1.04
Pendred's syndrome. Acoustic, vestibular and radiological findings in 17 unrelated patients. J Laryngol Otol (1987) 1.03
Gastrointestinal tuberculosis in patients with pulmonary tuberculosis. Q J Med (1990) 1.00
Unrelated bone marrow transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease. Bone Marrow Transplant (2003) 0.99
Calcium and potassium currents in spermatogenic cells dissociated from rat seminiferous tubules. J Physiol (1984) 0.99
Blood stem-cell transplantation for chronic active Epstein-Barr virus with lymphoproliferation. Lancet (2000) 0.97
Mosquito allergy and Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease. Blood (2001) 0.97
Hydroalcohol extract and fractions of Stachys lavandulifolia Vahl: effects on spontaneous motor activity and elevated plus-maze behaviour. Phytother Res (2005) 0.95
Medicine and management in European healthcare systems: how do they matter in the control of clinical practice? Int J Clin Pract (2011) 0.92
Allogeneic hematopoietic transplantation of CD34+ selected cells from an HLA haplo-identical related donor. A long-term follow-up of 135 patients and a comparison of stem cell source between the bone marrow and the peripheral blood. Bone Marrow Transplant (2000) 0.92
Observation of untreated patients with neuroblastoma detected by mass screening: a "wait and see" pilot study. Med Pediatr Oncol (2001) 0.91
High-performance size-exclusion chromatographic procedure for the determination of fluoresceinyl isothiocyanate dextrans of various molecular masses in biological media. J Chromatogr (1989) 0.90
Immunohistochemical detection of early myocardial infarction. An evaluation of antibodies against the terminal complement complex (C5b-9). Int J Legal Med (1995) 0.89
The influence of systemic therapy on the serum levels of IL-6 and IL-8 in pemphigus vulgaris. J Eur Acad Dermatol Venereol (2011) 0.89
Polymorphisms of transforming growth factor-beta1 and transforming growth factor-beta1 type II receptor genes are associated with acute graft-versus-host disease in children with HLA-matched sibling bone marrow transplantation. Bone Marrow Transplant (2002) 0.89
Effects of mass screening for neuroblastoma on incidence, mortality, and survival rates in Osaka, Japan. Cancer Causes Control (1998) 0.88
Changes in incidence and causes of non-relapse mortality after allogeneic hematopoietic cell transplantation in patients with acute leukemia/myelodysplastic syndrome: an analysis of the Japan Transplant Outcome Registry. Bone Marrow Transplant (2012) 0.87
Insulin-like growth factor receptor levels are regulated by cell density and by long term estrogen deprivation in MCF7 human breast cancer cells. J Biol Chem (2001) 0.87
Recent decrease in non-relapse mortality due to GVHD and infection after allogeneic hematopoietic cell transplantation in non-remission acute leukemia. Bone Marrow Transplant (2013) 0.86
Zinc-dependent action potentials in giant neurons of the snail, Euhadra quaestia. J Membr Biol (1979) 0.86
Impaired activity of plasma von Willebrand factor-cleaving protease may predict the occurrence of hepatic veno-occlusive disease after stem cell transplantation. Bone Marrow Transplant (2002) 0.86
Metal ion binding to apo, holo, and reconstituted horse spleen ferritin. J Inorg Biochem (1995) 0.86
Stratification of treatment of stage 4 neuroblastoma patients based on N-myc amplification status. Study Group of Japan for Treatment of Advanced Neuroblastoma, Tokyo, Japan. Med Pediatr Oncol (1998) 0.85
Lymphocyte proliferative responses to soluble and liposome-conjugated envelope peptides of HIV-1. J Immunol (1990) 0.85
KIR3DL1+HLA-B Bw4Ile80 and KIR2DS1+HLA-C2 combinations are both associated with ankylosing spondylitis in the Iranian population. Int J Immunogenet (2011) 0.85
Second allogeneic hematopoietic SCT for relapsed ALL in children. Bone Marrow Transplant (2012) 0.85
Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia. Bone Marrow Transplant (1999) 0.85
Long-term outcome of childhood aplastic anemia patients who underwent allogeneic hematopoietic SCT from an HLA-matched sibling donor in Japan. Bone Marrow Transplant (2012) 0.85
Cerebrospinal fluid penetration and pharmacokinetics of levofloxacin in an experimental rabbit meningitis model. J Antimicrob Chemother (2001) 0.84
Evidence that CD31, CD49b, and CD62L are immunodominant minor histocompatibility antigens in HLA identical sibling bone marrow transplants. Blood (1998) 0.84
Use of iotrolan versus ethiodized poppy-seed oil in hysterosalpingography. Radiology (1994) 0.84
Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease. Ann Oncol (2014) 0.84
Successful allogeneic stem cell transplantation from an unrelated donor for aggressive Epstein-Barr virus-associated clonal T-cell proliferation with hemophagocytosis. Int J Hematol (2001) 0.83
Photochemistry of quinolylmethylisothioronium salts. Guanine selective DNA photocleavage reagents. Photochem Photobiol (1991) 0.83
Kinetics of plasma cytokines after hematopoietic stem cell transplantation from unrelated donors: the ratio of plasma IL-10/sTNFR level as a potential prognostic marker in severe acute graft-versus-host disease. Bone Marrow Transplant (2001) 0.83
On the two subdivisions and intrinsic synaptic connexions in the submandibular ganglion of the rat. J Physiol (1984) 0.83
Cell mixing between the embryonic midbrain and hindbrain. Curr Biol (2001) 0.83
Modification of in vitro drug release rate from oily parenteral depots using a formulation approach. Eur J Pharm Sci (2000) 0.83
HIV infection at outcome of pregnancy in the Paris area, France. Lancet (1992) 0.83
Abdominal situs inversus in a sheep. N Z Vet J (1987) 0.82
Clonal change of infiltrating T-cells in children with familial hemophagocytic lymphohistiocytosis: possible association with Epstein-Barr virus infection. Cancer (1999) 0.82
Salvage allogeneic hematopoietic SCT for primary graft failure in children. Bone Marrow Transplant (2013) 0.82
The expression profile of functional regulatory T cells, CD4+CD25high+/forkhead box protein P3+, in patients with ulcerative colitis during active and quiescent disease. Clin Exp Immunol (2009) 0.82
Intraoperative ultrasonography in detection of hepatic metastases from colorectal cancer. Dis Colon Rectum (1995) 0.82
Hypertrophic pyloric stenosis: determination of muscle dimensions by ultrasound. Br J Radiol (1988) 0.81
End-point detection in a wet granulation process. Pharm Dev Technol (2001) 0.81
Allogeneic hematopoietic stem cell transplantation for patients with hemophagocytic syndrome (HPS) in Japan. Bone Marrow Transplant (1999) 0.81
Prophylactic fresh frozen plasma may prevent development of hepatic VOD after stem cell transplantation via ADAMTS13-mediated restoration of von Willebrand factor plasma levels. Bone Marrow Transplant (2007) 0.81
Effect of graft-versus-host disease on the outcome of bone marrow transplantation from an HLA-identical sibling donor using GVHD prophylaxis with cyclosporin A and methotrexate. Leukemia (2004) 0.81
Existence of rolipram-sensitive phosphodiesterase in rat megakaryocyte. Br J Pharmacol (1993) 0.81
Susceptibility to pulmonary tuberculosis in Iranian individuals is not affected by compound KIR/HLA genotype. Tissue Antigens (2011) 0.81
Tacrolimus (FK506) treatment of CD34+ hematopoietic progenitor cells promote the development of dendritic cells that drive CD4+ T cells toward Th2 responses. J Leukoc Biol (2000) 0.81
Prognostic factors for acute myeloid leukemia patients with t(6;9)(p23;q34) who underwent an allogeneic hematopoietic stem cell transplant. Leukemia (2011) 0.81
Allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia with t(6;9)(p23;q34) dramatically improves the patient prognosis: a matched-pair analysis. Leukemia (2011) 0.80
Multiple oral administration of a ketoprofen-dextran ester prodrug in pigs: assessment of gastrointestinal bioavailability by deconvolution. Pharm Res (1992) 0.80
Unrelated donor bone marrow transplantation for 100 pediatric patients: a single institute's experience. Bone Marrow Transplant (2005) 0.80
Health impact assessment as a tool for health promotion and population health. WHO Reg Publ Eur Ser (2001) 0.80
Sequence analysis of lysozyme C from the scorpion mesobuthus eupeus venom glands using semi-nested rt-PCR. Iran Red Crescent Med J (2011) 0.79
Assessment of rate of drug release from oil vehicle using a rotating dialysis cell. Eur J Pharm Sci (2000) 0.79
Interleukin-10 eliminates anti-CD3 monoclonal antibody-induced mortality and prolongs heart allograft survival in inbred mice. Transplant Proc (1995) 0.79
Diethyl methyl chitosan as an intestinal paracellular enhancer: ex vivo and in vivo studies. Int J Pharm (2005) 0.79
Macromolecular prodrugs. XV. Colon-targeted delivery--bioavailability of naproxen from orally administered dextran-naproxen ester prodrugs varying in molecular size in the pig. Pharm Res (1989) 0.79
Encouraging results of preserving ovarian function after allo-HSCT with RIC. Bone Marrow Transplant (2011) 0.79
Altered developmental changes of neuromuscular junction in hypo- and hyperthyroid rats. J Physiol (1982) 0.79
The all-fiber cladding-pumped Yb-doped gain-switched laser. Opt Express (2014) 0.78
C1-Inhibitor for treatment of acute vascular xenograft rejection in cynomolgus recipients of h-DAF transgenic porcine kidneys. Xenotransplantation (2001) 0.78
Comparison of the disposition of hepatically-generated morphine-3-glucuronide and morphine-6-glucuronide in isolated perfused liver from the guinea pig. Pharm Res (1997) 0.78
[CD34+ progenitor cell transplantation from HLA-mismatched donors to two patients with chronic active Epstein-Barr virus infection]. Rinsho Ketsueki (2001) 0.78
M-CSF attenuates severity of chronic GVHD after unrelated BMT. Bone Marrow Transplant (2011) 0.77
Long-term survival of cynomolgus monkeys following pig-to-primate kidney xenotransplantation using h-DAF transgenic donor organs. Transplant Proc (2000) 0.77
Translocation (14; 18) and (8; 22) in three patients with acute leukemia/lymphoma following centrocytic/centroblastic non-Hodgkin's lymphoma. Ann Hematol (1991) 0.77
Lack of clinical utility of minimal residual disease detection in allogeneic stem cell recipients with childhood acute lymphoblastic leukemia: multi-institutional collaborative study in Japan. Bone Marrow Transplant (2003) 0.77
Macromolecular prodrugs. XX. Factors influencing model dextranase-mediated depolymerization of dextran derivatives in vitro. Acta Pharm Nord (1992) 0.77
Allogeneic hematopoietic stem cell transplantation for intermediate cytogenetic risk AML in first CR. Bone Marrow Transplant (2012) 0.77